Recent Updates
Recently added Catalysts
BSX

Boston Scientific To Participate In BMO Capital Markets Prescriptions For Success Healthcare Conference Boston Scientific Corporation (NYSE: BSX) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, ...

Key Takeaway: MARLBOROUGH, Mass. , Dec. 4, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, 2017 in New York . Susie Lisa , vice president, investor relations, and Lindsa

Full Press Release Details

MARLBOROUGH, Mass. , Dec. 4, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX ) will participate in the BMO Capital Markets Prescriptions for Success Healthcare Conference on December 14, 2017 in New York .
Susie Lisa , vice president, investor relations, and Lindsay Fish , senior manager, investor relations will participate in a 30-minute question-and-answer session with the host analyst beginning at approximately 8:00 a.m. EST .
A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors . Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.
A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour after the completion of the event.
About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook .
CONTACTS
Media: Investors:
Kate Haranis Susie Lisa, CFA
508-683-6585 (office) 508-683-5565 (office)
Media Relations Investor Relations
Boston Scientific Corporation Boston Scientific Corporation
[email protected] [email protected]
SOURCE Boston Scientific Corporation

Related Links

21 %

Last updated: Dec 4, 2017